| Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress PE Lovat, M Corazzari, JL Armstrong, S Martin, V Pagliarini, D Hill, ... Cancer research 68 (13), 5363-5369, 2008 | 230 | 2008 |
| Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death JL Armstrong, DS Hill, CS McKee, S Hernandez-Tiedra, M Lorente, ... Journal of Investigative Dermatology 135 (6), 1629-1637, 2015 | 172 | 2015 |
| Real‐time cell cycle imaging during melanoma growth, invasion, and drug response NK Haass, KA Beaumont, DS Hill, A Anfosso, P Mrass, MA Munoz, ... Pigment cell & melanoma research 27 (5), 764-776, 2014 | 135 | 2014 |
| A novel fully humanized 3D skin equivalent to model early melanoma invasion DS Hill, NDP Robinson, MP Caley, M Chen, EA O'Toole, JL Armstrong, ... Molecular cancer therapeutics 14 (11), 2665-2673, 2015 | 124 | 2015 |
| Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibition JL Armstrong, M Corazzari, S Martin, V Pagliarini, L Falasca, DS Hill, ... Clinical Cancer Research 17 (8), 2216-2226, 2011 | 84 | 2011 |
| Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy N Mohana‐Kumaran, DS Hill, JD Allen, NK Haass Pigment cell & melanoma research 27 (4), 525-539, 2014 | 69 | 2014 |
| Combining the endoplasmic reticulum stress–inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanoma DS Hill, S Martin, JL Armstrong, R Flockhart, JJ Tonison, DG Simpson, ... Clinical Cancer Research 15 (4), 1192-1198, 2009 | 69 | 2009 |
| Targeting GRP78 to enhance melanoma cell death S Martin, DS Hill, JC Paton, AW Paton, MA Birch‐Machin, PE Lovat, ... Pigment cell & melanoma research 23 (5), 675-682, 2010 | 67 | 2010 |
| Cell cycle phase-specific drug resistance as an escape mechanism of melanoma cells KA Beaumont, DS Hill, SM Daignault, GYL Lui, DM Sharp, B Gabrielli, ... Journal of Investigative Dermatology 136 (7), 1479-1489, 2016 | 66 | 2016 |
| Targeting X-linked inhibitor of apoptosis protein to increase the efficacy of endoplasmic reticulum stress-induced apoptosis for melanoma therapy EL Hiscutt, DS Hill, S Martin, R Kerr, A Harbottle, M Birch-Machin, ... Journal of investigative dermatology 130 (9), 2250-2258, 2010 | 44 | 2010 |
| Oncogenic BRAF signalling increases M cl‐1 expression in cutaneous metastatic melanoma CS McKee, DS Hill, CPF Redfern, JL Armstrong, PE Lovat Experimental dermatology 22 (11), 767-769, 2013 | 39 | 2013 |
| Induction of endoplasmic reticulum stress as a strategy for melanoma therapy: is there a future? DS Hill, PE Lovat, NK Haass Melanoma management 1 (2), 127-137, 2014 | 21 | 2014 |
| G1 phase melanoma cells escape proteasome inhibitor cytotoxicity SM Daignault, DS Hill, KA Beaumont, A Anfosso, PE Lovat, W Weninger, ... Cancer Research 75 (15_Supplement), 1781-1781, 2015 | | 2015 |
| MITF regulates proliferative subpopulation tumor architecture and modifies invasion and characteristics of the epithelial to mesenchymal transition within melanoma CA Tonnessen, KA Beaumont, DS Hill, SM Daignault, A Anfosso, ... Cancer Research 75 (15_Supplement), 1420-1420, 2015 | | 2015 |
| Targeting XIAP to increase endoplasmic reticulum (ER) stress-induced apoptosis of malignant melanoma: 48 D Hill, E Hiscutt, S Martin, R Kerr, D Simpson, J Armstrong, S Fulda, ... Pigment Cell & Melanoma Research 22 (6), 874-875, 2009 | | 2009 |
